Houston, United States
The company has delivered 11 systems to customers in 5 countries and has 45 units in the order pipeline. Heliosonix's systems are based on patented and proprietary optoacoustic tomography and laser ultrasound technology. Additionally, the company is actively advancing the development of clinical products for human imaging. Heliosonix is a part of the Tomowave Medical Group, aiming to revolutionize the medical imaging field.
With its innovative technology and rapid growth, Heliosonix presents a compelling opportunity for investors looking to tap into the burgeoning market of medical imaging and preclinical research. This presents an exciting potential for return on investment, particularly as Heliosonix is poised to expand into the clinical imaging market. Moreover, the company's established customer base and robust order pipeline indicate strong market demand and potential for sustained growth.
